[ECMO for post cardiotomy refractory cardiogenic shock: Experience of the cardiac surgery department of the Grenoble Alpes University Hospital].
ECMO pour choc cardiogénique réfractaire post cardiotomie : expérience du service de chirurgie cardiaque du CHU de Grenoble Alpes.
Adult
Aged
Aged, 80 and over
Analysis of Variance
Cardiac Surgical Procedures
/ adverse effects
Extracorporeal Membrane Oxygenation
/ adverse effects
Female
Heart Arrest
/ mortality
Humans
Intra-Aortic Balloon Pumping
Male
Middle Aged
Postoperative Complications
/ etiology
Retrospective Studies
Risk Factors
Sex Factors
Shock, Cardiogenic
/ etiology
Stroke Volume
Survival Rate
Time Factors
Assistance circulatoire
Cardiac surgery
Chirurgie cardiaque
Circulatory support
ECMO
Post-cardiotomie
Post-cardiotomy
Refractory cardiogenic shock
choc cardiogénique réfractaire
Journal
Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
03
09
2020
accepted:
19
10
2020
pubmed:
1
3
2021
medline:
27
10
2021
entrez:
28
2
2021
Statut:
ppublish
Résumé
The objective of our study is to detail our experience relating to ECMO implantations for post-cardiotomy refractory shock, by analyzing the pre-ECMO factors (history, type of surgery, LVEF), factors relating to ECMO (implantation time, duration) and post-ECMO factors (weaning, complications) in order to highlight those possibly associated with high mortality. This is a univariate and multivariate retrospective study of ECMO data implemented between 2011 and 2019 at the Grenoble Alpes University Hospital Center following cardiac surgery. The time to implantation of ECMO was less than 3hours (intraoperative) between 3 and 24hours (early postoperative) and between 24 and 48hours after aortic unclamping (late postoperative). Preoperative or postoperative intra-aortic balloon counterpulsation (CPBIA) could be associated. 114 veino-arterial ECMOs were implanted for refractory cardiogenic shock after 5702 cardiac surgeries (1.9%) with a survival rate of 30.7%. The mean age of the patients was 68.6+- 10.5 years. The implantation of ECMO was performed intraoperatively in 71 patients (62.2%), early postoperatively in 22 patients (19.2%) and late postoperatively in 21 patients (18.4%). The duration of assistance was less than 48hours in 27 patients (23.6%), between 48hours and one week in 58 patients (50.9%) and more than one week in 29 patients (25.5%). Univariate analysis revealed a statistically significant association between mortality rate and male sex (P=0.002), association absent with other preoperative characteristics, delay in implantation of ECMO, installation of CPBIA, post-operative characteristics and resuscitation suites. Multivariate analysis of the entire study population demonstrated that the use of ECMO for cardio-respiratory arrest was the only independent risk factor for mortality (OR=7.57 [1.41-40, 62]). After multivariate reanalysis excluding patients with ECMO placement for cardio respiratory arrest, age, preoperative renal failure, type of procedure and EuroSCORE II were risk factors for mortality. In this study, male gender, type of intervention, occurrence of cardiac arrest were significantly associated with the death rate. A study of greater power, multicentric, and with a larger sample, will have to be carried out to reach significance.
Identifiants
pubmed: 33640147
pii: S0003-3928(20)30175-X
doi: 10.1016/j.ancard.2020.10.006
pii:
doi:
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
63-67Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.